Advertisement
News
Advertisement

Taro Says FDA Approves Psoriasis Treatment Spray

Fri, 04/12/2013 - 5:46pm
The Associated Press

Taro Pharmaceutical Industries Ltd. said Friday the Food and Drug Administration approved its Topicort spray as a treatment for plaque psoriasis.

The company said Topicort, or desoximetasone, is approved for patients age 18 and older. Taro said U.S. consumers spend about $100 million per year on corticosteroid sprays.

Taro shares gained a penny to $57.98 Friday.

Topics

Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading